{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:19:17Z","timestamp":1791645557572,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004528","name":"Maastricht Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtha.2026.01.021","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:48:50Z","timestamp":1771001330000},"page":"1665-1676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A chemiluminescent microfluidic thrombin generation assay for real-time monitoring in patient plasma"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8673-1065","authenticated-orcid":false,"given":"Theodora J.","family":"Steeghs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"van Engelshoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerissa M.M.","family":"Coolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia J.","family":"van de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri\u00ebtte W.","family":"Huijzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"van Geffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.A.","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia E.M.","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis van \u2019t","family":"Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waander L.","family":"van Heerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.01.021_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1538-7836.2007.02500.x","article-title":"The central role of thrombin in hemostasis","volume":"5","author":"Crawley","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-939550","article-title":"An overview of the structure and function of thrombin","volume":"32","author":"Davie","year":"2006","journal-title":"Sem Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib3","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/jth.15529","article-title":"Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine","volume":"19","author":"Depasse","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability","volume":"32","author":"Hemker","year":"2022","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.jtha.2026.01.021_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.jtha.2026.01.021_bib6","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtha.2022.11.029","article-title":"DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays \u2013 a review of the literature","volume":"21","author":"Shaw","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.thromres.2015.03.032","article-title":"How the direct oral anticoagulant apixaban affects thrombin generation parameters","volume":"135","author":"Tripodi","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.01.021_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/a-1981-1763","article-title":"Assessment of DOAC in GEriatrics (adage study): rivaroxaban\/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients","volume":"123","author":"Foulon-Pinto","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib10","article-title":"Thrombin generation and implications for hemophilia therapies: a narrative review","volume":"7","author":"Sidonio","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/hae.12570","article-title":"Monitoring bypassing agent therapy \u2013 a prospective crossover study comparing thromboelastometry and thrombin generation assay","volume":"21","author":"Tran","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.01.021_bib12","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.3324\/haematol.2017.185330","article-title":"Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab","volume":"103","author":"Dargaud","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.01.021_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/ijlh.14406","article-title":"Thrombin generation assay to support hematologists in the era of new hemophilia therapies","volume":"47","author":"Josset","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.01.021_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/hae.13493","article-title":"Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq (human-cl rhFVIII) in previously treated patients with severe haemophilia A","volume":"24","author":"Dargaud","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.01.021_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2010.32.8294","article-title":"Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study","volume":"29","author":"Ay","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtha.2026.01.021_bib16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1538-7836.2008.03018.x","article-title":"High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/rth2.12048","article-title":"A review of commercially available thrombin generation assays","volume":"2","author":"Kintigh","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2019-130875","article-title":"Novel thermostable inhibitor of contact activation Tica effectively blocks contact activation in low tissue factor thrombin generation","volume":"134","author":"Van de Bergh","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.021_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117469","article-title":"Novel microfluidic device for factor VIII quantification by chemiluminescence in hemophilia A patients","volume":"282","author":"Steeghs","year":"2025","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.jtha.2026.01.021_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1179\/102453311X13085644680348","article-title":"A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis","volume":"16","author":"van Geffen","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.jtha.2026.01.021_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030385","article-title":"Defining the boundaries of normal thrombin generation: investigations into hemostasis","volume":"7","author":"Danforth","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.01.021_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature05064","article-title":"Microfluidic diagnostic technologies for global public health","volume":"442","author":"Yager","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.01.021_bib23","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood.V88.9.3432.bloodjournal8893432","article-title":"Blood clotting in minimally altered whole blood","volume":"88","author":"Rand","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.021_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40560-016-0144-5","article-title":"Profiles of direct oral anticoagulants and clinical usage-dosage and dose regimen differences","volume":"4","author":"Ieko","year":"2016","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jtha.2026.01.021_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1517109","article-title":"The wonders of anticoagulation","volume":"11","author":"Ten Cate","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2026.01.021_bib26","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/jgs.18894","article-title":"The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: an exploratory study","volume":"72","author":"de Jong","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jtha.2026.01.021_bib27","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/ijlh.13356","article-title":"Are the DOAC plasma level thresholds appropriate for clinical decision-making? A reappraisal using thrombin generation testing","volume":"43","author":"Evrard","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.01.021_bib28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/ijlh.13618","article-title":"Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants","volume":"43","author":"Metze","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.01.021_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ijlh.13721","article-title":"Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA","volume":"44","author":"Pfrepper","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.01.021_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.thromres.2023.01.022","article-title":"Thrombin generation in real life bleeding patients on oral anticoagulants reversed (or not) with (activated) prothrombin complex concentrate","volume":"223","author":"Teissandier","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.01.021_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/rth2.12044","article-title":"Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay","volume":"1","author":"Artang","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib32","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2017.174037","article-title":"Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma","volume":"102","author":"Ersayin","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.01.021_bib33","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.3390\/jcm13226842","article-title":"Urgent reversal of direct oral anticoagulants in critical and life-threatening bleeding: a multidisciplinary expert consensus","volume":"24","author":"Rodrigues","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.01.021_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101164","article-title":"Nothing short of a revolution: novel extended half-life factor VIII replacement products and non-replacement agents reshape the treatment landscape in hemophilia A","volume":"64","author":"Abdelgawad","year":"2024","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2026.01.021_bib35","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/bloodadvances.2019000849","article-title":"Laboratory monitoring of hemophilia A treatments: new challenges","volume":"4","author":"Lenting","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.01.021_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102576","article-title":"Thrombin generation to evaluate the complex hemostatic balance of hemophilia A plasma containing direct oral anticoagulant and supplemented by factor VIII","volume":"8","author":"Lamoine","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.021_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109045","article-title":"Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: a comprehensive assessment","volume":"240","author":"Haisma","year":"2024","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:59:30Z","timestamp":1783972770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538783626001066"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.021","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chemiluminescent microfluidic thrombin generation assay for real-time monitoring in patient plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}